Litcius/Paper detail

GDI2 is a target of paclitaxel that affects tumorigenesis of prostate cancer via the p75NTR signaling pathway

Chi Liu, Wei Wang, Ping Lin, Hui Xie, Shan Jiang, Huizhen Jia, Rou Li, Nan Wang, Xiaoguang Yu

2021Biochemical and Biophysical Research Communications20 citationsDOI

Topics & Concepts

Prostate cancerCarcinogenesisCancer researchCell growthCancerProstatePaclitaxelApoptosisSignal transductionCellMedicineBiologyInternal medicineCell biologyGeneticsBiochemistryCancer, Hypoxia, and MetabolismIon Transport and Channel RegulationMetabolism, Diabetes, and Cancer
GDI2 is a target of paclitaxel that affects tumorigenesis of prostate cancer via the p75NTR signaling pathway | Litcius